Article information
Full text is only available in PDF
Bibliografía
[1.]
M.A. Woodhead, J.T. Macfarlane, J.S. McCraken, D.H. Rose, R.G. Finch.
Prospective study of the aetiology and outcome of pneumonia in the community.
Lancet, 1 (1987), pp. 671-674
[2.]
C. Jokinen, L. Heiskanen, H. Juvonen, S. Kallinen, K. Karkola, M. Korppi, et al.
Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland.
Am J Epidemiol, 137 (1993), pp. 977-988
[3.]
H.M. Foy, M.K. Cooney, I. Allan, G.E. Kenny.
Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975.
Jama, 241 (1979), pp. 253-258
[4.]
M.R. Suchyta, N.C. Dean, S. Narus, C.J. Hadlock.
Effects of a practice guideline for community-acquired pneumonia in an outpatient setting.
Am J Med, 110 (2001), pp. 306-309
[5.]
T.J. Marrie, C.Y. Lau, S.L. Wheeler, C.J. Wong, M.K. Vandervoort, B.G. Feagan.
A controlled trial of a critical pathway for treatment of community-acquired pneumonia.
Jama, 283 (2000), pp. 749-755
[6.]
J. Almirall, I. Bolíbar, J. Vidal, G. Sauca, P. Coll, B. Niklasson, et al.
Epidemiology of community-acquired pneumonia in adults: a population- based study.
Eur Respir J, 15 (2000), pp. 757-763
[7.]
M.J. Fine, M.A. Smith, C.A. Carson, S.S. Mutha, S.S. Sankey, L.A. Weissfeld, et al.
Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis.
Jama, 275 (1996), pp. 134-141
[8.]
S. Ewig, M. Ruiz, J. Mensa, M.A. Marcos, J.A. Martínez, F. Arancibia, et al.
Severe community-acquired pneumonia. Assessment of severity criteria.
Am J Respir Crit Care Med, 158 (1998), pp. 1102-1108
[9.]
D. McCormick, M.J. Fine, C.M. Coley, T.J. Marrie, J.R. Lave, D.S. Obronsky, et al.
Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes?.
Am J Med, 107 (1999), pp. 5-12
[10.]
J.E. Wennberg, J.L. Freeman, W.J. Culp.
Are hospital services rationed in New Haven or over-utilised in Boston?.
Lancet, 1 (1987), pp. 1185-1189
[11.]
J. Dorca, S. Bello, J. Blanquer, R. De Celis, I. Molinos, A. Torres, et al.
Diagnóstico y tatamiento de la neumonía adquirida en la comunidad.
Arch Bronconeumol, 33 (1997), pp. 240-246
[12.]
J. Macfarlane, T. Boswell, G. Douglas, R. Finch, W. Holmes, D. Honeybourne, et al.
BTS guidelines for the management of communityacquired pneumonia in adults.
Thorax, 156 (2001), pp. 1-64
[13.]
A.M. Neill, I.R. Martin, R. Weir, R. Anderson, A. Chereshsky, M.J. Epton, et al.
Community acquired pneumonia: aetiology and usefulness of severity criteria on admission.
Thorax, 51 (1996), pp. 1010-1016
[14.]
B.M. Farr, A.J. Sloman, M.J. Fisch.
Predicting death in patients hospitalized for community-acquired pneumonia.
Ann Intern Med, 115 (1991), pp. 428-436
[15.]
W.S. Lim, J.T. Macfarlane, T.C. Boswell, T.G. Harrison, D. Rose, M. Leinonen, et al.
Study of community-acquired pneumonia aetiology in adults admitted to hospital: implications for management guidelines.
Thorax, 56 (2001), pp. 296-301
[16.]
M.S. Niederman, L.A. Mandell, A. Anzueto, J.B. Bass, W.A. Broughton, G.D. Campbell, et al.
Guideline for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention.
Am J Respir Crit Care Med, 163 (2001), pp. 1730-1754
[17.]
M.J. Fine, T.E. Auble, D.M. Yealy, B.H. Hanusa, L.A. Weissfeld, D.E. Singer, et al.
A prediction rule to identify low-risk patients with community-acquired pneumonia.
N Engl J Med, 336 (1997), pp. 243-250
[18.]
D. Aronsky, N.C. Dean.
How should we make the admission decision in community-acquired pneumonia?.
Med Clin North Am, 85 (2001), pp. 1397-1411
[19.]
S.J. Atlas, T.I. Benzer, L.H. Borowsky, Y. Chang, D.C. Burnham, J.P. Metlay, et al.
Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients.
Arch Intern Med, 158 (1998), pp. 1350-1356
[20.]
A. Ruiz, M. Vallverdú, M. Falguera, J. Perez, X. Cabré, M. Almirall, et al.
Neumonía adquirida en la comunidad: impacto de la utilización de una estrategia terapéutica basada en la mortalidad a corto plazo.
Med Clin (Barc), 113 (1999), pp. 85-88
[21.]
B. Rosón, J. Carratalá, J. Dorca, A. Casanova, F. Manresa, F. Gudiol.
Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria.
Clin Infect Dis, 33 (2001), pp. 158-165
[22.]
R. Menéndez, D. Ferrando, J.M. Vallés, E. Martinez, M. Perpiñá.
Initial risk class and length of hospital stay in community-acquired pneumonia.
Eur Respir J, 18 (2001), pp. 151-156
[23.]
T.K. Marras, C. Gutiérrez, C.K. Chan.
Applying a prediction rule to identify low-risk patients with community-acquired pneumonia.
Chest, 118 (2000), pp. 1339-1343
[24.]
J. González-Moraleja, P. Sesma, C. González, M.E. López, J.F. García, J.L. Álvarez-Sala.
¿Cuál es el coste de las neumonías que ingresamos inadecuadamente?.
Arch Bronconeumol, 35 (1999), pp. 312-316
[25.]
P. España, A. Capelastegui, J.M. Quintana, A. Soto, I. Gorordo, M. Garcia- Urbaneja, et al.
A prediction rule to identify allocation of inpatient care in community-acquired pneumonia.
Eur Respir J, (2002),
Copyright © 2002. Sociedad Española de Neumología y Cirugía Torácica
